- Finland suspends use of modern COVID-19 vaccine over fears of rare heart inflammation in men under 30
- instead there will be young men and boys Pfizer-BioNTech Vaccine Offered
- Nordic nation joins nearby Denmark and Sweden in curbing vaccine use among young people
- Sweden will no longer allow anyone born after 1990 to receive the Modern shot and anyone under the age of 18 will not be able to get the shot in Denmark
- The CDC warns that heartburn is a possible side effect of the vaccine when used in young men.
- A recent study found that people who contract COVID are more likely to develop heart inflammation than those who receive the vaccine
Finland has become the latest Nordic nation to stop the use of the Moderna COVID-19 vaccine in young people, over fears that the shots are causing rare heart inflammation.
The Finnish Institute for Health and Welfare said on Thursday that officials would not give the vaccine to men under the age of 30, and they would be offered the Pfizer-BioNtech vaccination instead.
The government agency said it found that young men and boys had a slightly higher risk of developing myocarditis.
This comes after health officials in Sweden and Denmark made a similar decision earlier this week.
In Sweden, the Modern jab will no longer be available to anyone born after 1990 or aged 30 and under.
Denmark has restricted access to the vaccine to anyone under the age of 18.
Norway, another Nordic country, has not acted as harshly as its neighbors, with health officials urging people under 30 to opt for the Pfizer vaccine instead.
All four countries based their decision on an unpublished study with Sweden’s Public Health Agency saying it indicated an ‘increased risk of side effects such as inflammation of the heart muscle or the pericardium’ – the double-walled wall containing the heart and roots. Pouch main vessels.
It added: ‘The risk of being affected is very low.’
Modern vaccines have been banned in Sweden since 1990 and in Denmark for people under the age of 18 (file photo)
The Moderna vaccine has been linked to cases of heart inflammation, especially in young people, which has led Nordic countries to ban its use in certain populations. Pictured: A woman receives a dose of a COVID-19 vaccine on September 11 in Eshoj, Denmark
Myocarditis and pericarditis, both types of heart inflammation, are known side effects of COVID vaccines, and the Centers for Disease Control and Prevention (CDC) even warns that the condition may develop in young men after vaccination.
Inflammation of the heart is also a symptom of many viral infections, such as COVID-19, however, and the likelihood of developing inflammation after infection is much higher than after vaccination.
The Swedish health agency said it would stop using the shot for people born in 1991 and later data pointed to an increase in myocarditis and pericarditis among youth and young adults who had been vaccinated.
This stay will last till December 1.
Those conditions include inflammation of the heart or its lining.
The health agency said, ‘The connection is particularly clear when it comes to Moderna’s vaccine SpikeVax, especially after the second dose.
A spokesperson for Moderna said in an email that the company was aware of decisions by regulators in Denmark and Sweden to halt the use of its vaccine in young individuals because of the rare risk of myocarditis and/or pericarditis.
“These are usually mild cases and individuals recover within a short period of time after standard treatment and rest,” he wrote.
‘People infected with COVID-19 are at significantly increased risk of myocarditis and vaccination is the best way to prevent it.’
According to a US study that has yet to undergo peer review, young men under the age of 20 are six times more likely to develop myocarditis after contracting COVID-19 than those who have been vaccinated. has been applied.
Denmark said that, while it used the Pfizer-BioNTech vaccine as its main option for people aged 12 to 17, it has decided to stop giving the modern vaccine to people under 18 according to the ‘precautionary principle’. had decided.
In June, CDC issued a warning that young men were at increased risk of myocarditis after receiving the vaccine.
The labels for both the Pfizer and Moderna vaccines were changed to reflect the warning in the US, although use was never stopped.
Cases of post-vaccination swelling are rare, although they are often enough to worry regulators.
A recent study by Kaiser Permanente Southern California found that about seven out of every million people who get the two-shot COVID-19 vaccine will develop myocarditis.
A recent study by KPSC found that people who received the COVID vaccine were seven times more likely to develop heartburn after the second dose of the jab. However, people who have not been vaccinated have a significantly higher chance of developing myocarditis.
The same study found that 47.5 out of every one million COVID patients experience heart inflammation.
While myocarditis often gets better on its own, it can be dangerous.
Inflammation of the heart can often cause fatigue, shortness of breath and chest pain for patients.
People with an inflamed heart have a higher risk of heart failure, heart attack, and stroke.
Attempting strenuous physical activity with an inflamed heart can potentially lead to sudden cardiac arrest or even death.